Transformative Treatments Results in Plaque Psoriasis and Psoriatic Arthritis
- This event has passed.
Transformative Treatments Results in Plaque Psoriasis and Psoriatic Arthritis
Speaker: April W. Armstrong, MD, FAAD Professor and Chief of Dermatology UCLA Health Professor of Dermatology Associate Dean for Clinical Research Director of Clinical Research Support, Southern California Clinical and Translational Science Institute (SC CTSI)
Moderator: Leon Kircik, MD, FAAD President, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY
Please join us for our next IDEF Educational Series Webinar: Transformative Treatments Results in Plaque Psoriasis and Psoriatic Arthritis with the First and Only Approved IL – 17A and IL17F Inhibitor. BIMZELX is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, active psoriatic arthritis, active non-radiographic axial spondyloarthritis with objective signs of inflammation, active ankylosing spondylitis, and moderate-to-severe hidradenitis suppurativa.